Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

112 trials with published results (18%)

Research Maturity

393 completed trials (64% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.3%

45 terminated out of 615 trials

Success Rate

89.7%

+3.1% vs benchmark

Late-Stage Pipeline

16%

99 trials in Phase 3/4

Results Transparency

28%

112 of 393 completed with results

Key Signals

112 with results90% success45 terminated

Data Visualizations

Phase Distribution

495Total
Not Applicable (259)
Early P 1 (5)
P 1 (47)
P 2 (85)
P 3 (40)
P 4 (59)

Trial Status

Completed393
Unknown85
Terminated45
Recruiting38
Withdrawn21
Active Not Recruiting20

Trial Success Rate

89.7%

Benchmark: 86.6%

Based on 393 completed trials

Clinical Trials (615)

Showing 20 of 20 trials
NCT07793929Phase 1RecruitingPrimary

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

NCT04399941Not ApplicableRecruitingPrimary

Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis

NCT07216885Not ApplicableTerminatedPrimary

Solv Multi-Pass Hemodialysis System In-Center Clinical Study

NCT01974999Completed

A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 Study

NCT04392440Not ApplicableCompletedPrimary

Shared Decision Making in Dialysis

NCT04064086Not ApplicableActive Not Recruiting

Trial to Evaluate and Assess the Effect of Comprehensive Pre-ESKD Education on Home Dialysis Use in Veterans

NCT03032835Recruiting

Partners Calciphylaxis Biobank

NCT05726526Not ApplicableRecruiting

CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients

NCT05282732Completed

Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Haemodialysis Patients

NCT07058909Not ApplicableCompleted

Premarket Clinical Safety Assessment of the ELISIO™-HX

NCT01475123Phase 4Active Not Recruiting

Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil

NCT07020832Phase 3Withdrawn

Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation

NCT07696962Phase 1Not Yet RecruitingPrimary

Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease

NCT07591714Not ApplicableEnrolling By InvitationPrimary

The Effect of Intradialytic Eye Exercise in Hemodialysis Patients

NCT06313892Not ApplicableCompletedPrimary

The Effect of Home-Based Tele-Exercise on Dialysis Patients

NCT05705414Early Phase 1CompletedPrimary

Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis

NCT06310161Not ApplicableActive Not RecruitingPrimary

Light Therapy in End Stage Kidney Disease

NCT02644941Phase 3Completed

Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis

NCT06609343Phase 1Not Yet RecruitingPrimary

Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis

NCT06439862Recruiting

Study of the Quality of Life in School Aged-children With Posterior Urethral Valves

Scroll to load more

Research Network

Activity Timeline